CEO insider sales at Eton Pharmaceuticals signal a tactical liquidity move, not a crisis, but investors should watch earnings and pipeline updates closely.
Insider buying at Eton Pharmaceuticals signals confidence in its low‑priced, high‑potential pipeline, offering investors a contrarian entry point amid a 12‑week decline.